Back

Edoxaban vs warfarin in vitamin K antagonist experienced and naive patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial

26 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 2 - Atrial fibrillation ablation Rhythm Control, Cardioversion ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

29 More presentations in this session

Presentation thumbnail
Professor Y. Oh (Seoul, KR)
Abstract Slides
Presentation thumbnail
Associate Professor H. Yu (Seoul, KR)
Abstract
Presentation thumbnail
Doctor S. Otuki (Osaka, JP)
Abstract
Presentation thumbnail
Doctor V. Rubesch-Kuetemeyer (Detmold, DE)
Abstract Slides
Presentation thumbnail
Professor G. Conte (Lugano, CH)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Atrial fibrillation ablation

The Event

Event poster

ESC Congress 2018

26 August 2018 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources